NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 5.7 percent, or $.22, at $4.09 after the stock was upgraded by an investment bank today.
 
Piper Jaffray upgraded the stock to “outperform” from “market perform.”
 
Decode posted a 17-percent spike in fourth-quarter revenues last week, as R&D spending rose 4 percent and loss increased 10 percent. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.